Faeth Therapeutics
FTH
24.92
-1.97
-7.33%
Faeth Therapeutics
US · FTH
#3576 by market cap
Listed 2021
24.92
-1.97
-7.33%
Live - 5344 symbols - heartbeat 8s ago
· 2026-10-08 08:56
Pre-market
24.87
-0.20%
After-hours
24.92
0.00%
- Market cap
- 643.94M
- P/E (TTM)i
- -0.41
- P/Bi
- 3.72
- EPSi
- -16.72
- Div yieldi
- 0.00%
- 52W posi
- 50%
Reader sentiment
Are you bullish or bearish on FTH?
Anonymous reader poll. Unscientific, not investment advice.
About Faeth Therapeutics
Faeth Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Austin, TX.
- Founded
- 1999
- CEO
- Mr. Anand Kiran Parikh
- Employees
- 29
- Headquarters
- Austin, Texas, United States of America
- Fiscal year end
- 12-31
- Website
- faeththerapeutics.com
Company profile
- Exchange
- US
- Symbol
- FTH
- Market-cap rank
- #3576
- Listing date
- 2021-02-04
- Market cap
- 643.94M
- Float cap
- 461.30M
- Shares out
- 25.84M
- Float shares
- 18.51M
Sectors & themes
Quote time 2026-10-08 08:56:25 · For reference only, not investment advice and not tailored to your situation.